Screener
Aquestive Therapeutics, Inc. AQST Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
FAQ
- What is Aquestive Therapeutics, Inc.'s net margin?
- Aquestive Therapeutics, Inc. (AQST) reported net margin of -137.1% in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s net margin changed year-over-year?
- Aquestive Therapeutics, Inc.'s net margin decreased by 37.1% year-over-year, from -100% to -137.1%.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s net margin?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s net margin has grown at a 9.1% compound annual growth rate (CAGR), from -121.7% to -188.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Aquestive Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude